*October 2022*
Dr. Neil Love and Dr. Pasi Janne discuss the current and future management of EGFR+ NSCLC. Listen to the audio or read the transcription.
*October 2022*
Dr. Neil Love and Dr. Pasi Janne discuss the current and future management of EGFR+ NSCLC. Listen to the audio or read the transcription.





The EGFR Resisters is a global community of patients and caregivers impacted by EGFR-positive lung cancer. We’re here to share knowledge, offer support and collaborate to drive progress in research and care. We are here to share treatment experiences, information about clinical trials, breaking news about research developments, and other information with each other.
